Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:47 AM
Ignite Modification Date:
2025-12-25 @ 3:47 AM
NCT ID:
NCT05892302
Eligibility Criteria:
Inclusion Criteria:
1. Provision of signed and dated informed consent forms.
2. Who has a child who is 5-12 years of age
3. Whose child meets criteria for current persistent asthma defined as either:
1. On a long-term controller medication for asthma, or
2. Meet NAEPP guideline requirements for persistent disease:)(35)
* Asthma symptoms 3 or more days per week over the past 2 weeks OR
* Nocturnal asthma symptoms at least 3 times in the past month
4. Whose child has had an asthma exacerbation, defined as an oral steroid burst, in the previous 12 months
5. Parent/Caregiver identifies as Mexican American or other Hispanic descent
6. Whose child has clinician diagnosed asthma
7. Access to necessary resources for participating in a technology-based intervention (i.e., computer, smart phone, internet access)
8. Whose child is not currently participating in another asthma study.
The parent/caregiver is the primary study participant, but the child will be asked to complete some surveys at baseline and six months, so an assent will be obtained from the child.
Exclusion Criteria:
* An individual who meets any of the following criteria will be excluded from participation in this study:
1. Unwilling to provide consent for research activities
2. Cognitive inability to provide consent
3. Whose child has evidence of other chronic lung or significant cardiovascular disease
4. Whose child has a history of intubation for asthma
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
5 Years
Maximum Age:
12 Years
Study:
NCT05892302
Study Brief:
Protocol Section:
NCT05892302